New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44)

The summary for the New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44): This FOA is to encourage Small Business Innovation Research (SBIR) applications for research to develop reagents, tools and technologies to accelerate research on lymphatic vessel physiology and pathophysiology in digestive system and urinary tract organs. The announcement does not focus on immune mechanisms; however tools that will aid studies to understand the factors that direct local lymphatic vessel functional anatomy and physiology during health, inflammation and disease in digestive and urinary tract organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest.
Federal Grant Title: New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44)
Federal Agency Name: National Institutes of Health
Grant Categories: Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-12-258
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Digestive, and Kidney Diseases Extramural Research
Current Application Deadline: Sep 07, 2015
Original Application Deadline: Sep 07, 2015
Posted Date: Aug 08, 2012
Creation Date: Aug 08, 2012
Archive Date: Oct 08, 2015
Total Program Funding:
Maximum Federal Grant Award: $150,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com